Kingsway Trading Inc. Recalls “Xanthium & Siler Combo (Bi Yan Pian) Dietary Supplement” Because it Contains Banned Ephedra Alkaloids
- Company Announcement Date:
- February 07, 2017
- FDA Publish Date:
- February 07, 2018
- Product Type:
- Dietary Supplements
Food & Beverage Safety
- Reason for Announcement:
Recall Reason DescriptionContains Banned Ephedra Alkaloids
- Company Name:
- Kingsway Trading Inc.
- Brand Name:
Brand Name(s)Well Balance
- Product Description:
Product DescriptionDietary Supplement
Kingsway Trading Inc. Recalls “Xanthium & Siler Combo (Bi Yan Pian) Dietary Supplement” because it Contains Banned Ephedra Alkaloids
Kingsway Trading Inc. of Brooklyn, NY is recalling its 1.06 oz (30g) bottles of “Well Balance Xanthium & Siler Combo (Bi Yan Pian)” Batch No. 130401 & Batch No. 150201 because they contain the presence of undeclared Ephedra Herba (ma huang), an FDA banned item. Dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events, including heart attack, stroke, and death, and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use, or under ordinary conditions of use if the labeling is silent.
Product was distributed to: MA, NJ, NY, IL, MD, FL, MO, TX, IN, GA, DE, CO, VA, PA, CT, OR, VA, AZ, Through our vendor such as oriental herb store, acupuncture clinic and Oriental supermarket. These retail business distribute to their individual customers.
The item is packed in a plastic brown bottle with white cap. Each bottle contains 100 Tablets, each tablet is 300mg.
No illnesses have been reported to date.
During an FDA inspection, it was discovered that the product contained ephedra herba. The company has ceased the production and distribution of the product.
Consumers who have purchased the product are urged to return them to the place of purchase for a full refund. Consumers with questions may contact the company at (718)366-2300, From Monday to Friday. 9:00am to 5:00pm
Company Contact Information